Results 191 to 200 of about 48,475 (244)
Some of the next articles are maybe not open access.
Annals of Pharmacotherapy, 1992
OBJECTIVE: The primary objective of this article is to introduce readers to the use of a new agent, pamidronate. The article discusses its use in hypercalcemia of malignancy (HCM), osteolytic lesions, and Paget's disease.
M J, Kellihan, P D, Mangino
openaire +4 more sources
OBJECTIVE: The primary objective of this article is to introduce readers to the use of a new agent, pamidronate. The article discusses its use in hypercalcemia of malignancy (HCM), osteolytic lesions, and Paget's disease.
M J, Kellihan, P D, Mangino
openaire +4 more sources
Acta Crystallographica Section C Crystal Structure Communications, 2002
The title compound, disodium 3-ammonium-1-hydroxypropylidene-1,1-bisphosphonate pentahydrate, 2Na(+).C(3)H(9)NO(7)P(2)(2-).5H(2)O, is used for the diagnosis and treatment of a number of bone disorders. In the solid state, disodium pamidronate shows zwitterionic character and has four different modes of chelation to sodium.
Daniel, Vega +2 more
openaire +2 more sources
The title compound, disodium 3-ammonium-1-hydroxypropylidene-1,1-bisphosphonate pentahydrate, 2Na(+).C(3)H(9)NO(7)P(2)(2-).5H(2)O, is used for the diagnosis and treatment of a number of bone disorders. In the solid state, disodium pamidronate shows zwitterionic character and has four different modes of chelation to sodium.
Daniel, Vega +2 more
openaire +2 more sources
Pamidronate in the treatment of childhood SAPHO syndrome [PDF]
British Journal of Rheumatology, 2004 A G Cleary +2 more
exaly +2 more sources